Predict your next investment

Enzyre company logo
HEALTHCARE | Medical Devices & Equipment / Surgical Devices
enzyre.com

See what CB Insights has to offer

Founded Year

2016

Stage

Bridge | Alive

Total Raised

$1.64M

Last Raised

$1.64M | 1 yr ago

About Enzyre

Enzyre is a UMC St. Radboud spin-off company that develops diagnostic solutions in medical devices to enable personalized medicine.

Enzyre Headquarter Location

Transistorweg 5

Nijmegen, 6534,

Netherlands

+31 024 6690036

Latest Enzyre News

This Dutch startup is developing Enzypad to bring the lab to haemophilia patients, bags €1.4M funding

Jul 28, 2020

Raised €1.4M Corona Bridge Loan In the latest development, Enzyre secured €1.4M Corona Bridge Loan granted by the Dutch government in support of innovative startups and scaleups. Novalis Biotechnology Incubation that provides seed funding and ongoing support to biotechnology and life sciences companies also participated in the funding round. The EIT Digital Challenge 2020 Take a look at previous winners and how they took up the challenge by doing what they do... Show More Take a look at previous winners and how they took up the challenge by doing what they do best: innovate. Show Less Dirk Pollet, CEO of Enzyre commented: “We are pleased to welcome Novalis Biotechnology Incubation to our investor base. The Novalis team is very well aligned with Enzyre’s strategy to “bring the laboratory to the patient”, enabling them to avoid hospital visits. We firmly believe there is a huge demand for technology that empowers patients and allows healthcare workers to provide the best therapy without delay and increased cost. Enzypad can meet this demand.“ The first application of Enzypad will revolutionize monitoring of hemophilia by providing a real-time picture of a patient’s blood coagulation status. The result of each test made by a patient is sent automatically to the treating physicians through an app on a mobile phone. Growing need for NPT tools Right now, there is a growing need for NPT (Near Patient Test) tools, which offer patients and healthcare workers the possibility for remote personalized and data-based disease management via telemedicine, avoiding hospital visits and reducing healthcare costs. Enzyre’s platform technology is unique as it requires just a small volume of blood and can measure up to twelve (12) biomarkers simultaneously without any laboratory infrastructure; at home, on the road, or in a critical care setting. Small hand-held diagnostic tool  Furthermore, Enzyre’s proprietary technology is a small hand-held diagnostic tool using disease-specific single-use microfluidic cartridges with high sensitivity and specificity. It has broad applicability in several disease areas. In December 2019, Enzyre signed a collaboration with Takeda for the development of Enzypad in congenital bleeding disorders, validating this innovative approach. Prof. Wim Van Criekinge, co-founder of Novalis added: “Near patient testing presents a major opportunity in today’s world to obtain an improved treatment outcome for patients. More and better data is an essential element in our drive to advance healthcare. We were impressed by the Enzyre team and Enzypad technology, which has many application areas beyond coagulation testing. Our investment in Enzyre perfectly matches our strategy of investing in innovative breakthrough technology in life sciences.” Main image credits: Enzyre

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Enzyre

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Enzyre is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

7,884 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Enzyre Patents

Enzyre has filed 1 patent.

The 3 most popular patent topics include:

  • Anticoagulants
  • Blood tests
  • Coagulation system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/17/2019

Coagulation system, Coagulopathies, Anticoagulants, Blood tests, Hematology

Application

Application Date

10/17/2019

Grant Date

Title

Related Topics

Coagulation system, Coagulopathies, Anticoagulants, Blood tests, Hematology

Status

Application

Enzyre Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Enzyre Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.